AstraZeneca (NYSE:AZN) announced today that, in 2013, it provided nearly
$975 million in savings to more than 567,000 patients in the United
States through its patient assistance programs. These programs include AZ&Me
and the MedImmune
Assistance Program.
“At AstraZeneca, we work hard to understand the needs of patients, and
we’re committed to helping them afford their medications,” said Paul
Hudson, President, AstraZeneca U.S. and Executive Vice President, North
America. “For more than 35 years, our patient assistance programs have
been helping people access the medicines they need, and we look forward
to bringing them continued savings and benefits in 2014.”
AstraZeneca’s AZ&Me prescription savings programs are designed to help
qualifying people without insurance, those in Medicare Part D, those who
receive their medications through participating health care facilities,
and those who have faced a financial challenge recently.
-
Individuals without Prescription Drug Coverage: AstraZeneca
provides free medicines to qualifying individuals with an annual
income at or below $35,000 and families of four with an annual
household income at or below $70,000.
-
Part D Beneficiaries: AstraZeneca provides free medicines to
qualifying Medicare Part D beneficiaries with an annual income at or
below $35,000 and couples with an annual household income at or below
$48,000.
-
Healthcare Facilities: AstraZeneca provides free medicines to
qualifying non-profit organizations, such as disproportionate share
hospitals, community health centers and community free clinics. This
program helps provide medicines to qualifying patients at the time and
place of treatment.
The MedImmune Assistance Program provides medication free of charge to
qualified patients who are uninsured, or who have been rendered
uninsured by their insurance company. Qualified patients must meet all
eligibility criteria.
Click here
for a visual overview of AstraZeneca’s prescriptions savings programs.
For more detailed information about the AZ&Me prescription savings
programs, please visit www.astrazeneca-us.com or
call 1-800-AZandMe (292-6363). For additional information about the
MedImmune Assistance Program, visit www.myAccess360.com
or call 1-877-778-9010.
AstraZeneca also participates in multi-manufacturer programs like the
Partnership for Prescription Assistance and supports other
organizations with the same goal—increasing access to medicines as
well as health care.
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business
that focuses on the discovery, development and commercialization of
prescription medicines, primarily for the treatment of cardiovascular,
metabolic, respiratory, inflammation, autoimmune, oncology, infection
and neuroscience diseases. AstraZeneca operates in over 100 countries
and its innovative medicines are used by millions of patients worldwide.
For more information about AstraZeneca in the U.S. or our AZ&Me™
Prescription Savings programs, please visit: www.astrazeneca-us.com
or call 1-800-AZandMe (292-6363).
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140220005341/en/
Copyright Business Wire 2014